封面
市場調查報告書
商品編碼
1741461

全球藥品折扣卡市場按類型、治療類別、銷售管道和地區分類

Drug Discount Card Market, By Type, By Therapeutic Category, By Sales Channel,, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2025 年全球藥品折扣卡市場規模為 19.562 億美元,到 2032 年將達到 33.744 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 8.1%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 19.562億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 8.10% 2032年價值預測 33.744億美元

藥品折扣卡已成為消費者節省處方藥費用的熱門方式。隨著醫療費用的上漲,這些折扣卡為個人和家庭提供了急需的經濟援助。其原理很簡單:在參與活動的藥局出示您的藥品折扣卡,即可享有處方箋折扣價。

市場動態:

藥品折扣卡市場的發展受到多種因素的驅動。首先,人們對平價醫療方案的需求日益成長,這導致了藥品折扣卡的激增。醫療成本的上漲和處方箋藥價格的居高不下,促使消費者積極尋求節省藥費的方法。

推動這一市場發展的另一個因素是慢性病的普遍性。隨著慢性病患者人數的不斷增加,處方藥的需求也隨之增加。藥品折扣卡為依賴藥物治療的患者提供了方便且經濟實惠的解決方案。

然而,市場中存在一些限制因素。藥品折扣卡面臨的挑戰之一是並非所有藥局都接受。雖然許多大型藥局接受這些卡,但仍有一些小型藥局不參與此類計畫。對於喜歡使用本地或獨立藥局的消費者來說,這種有限的接受度可能是一個障礙。

儘管面臨諸多挑戰,藥品折扣卡市場仍蘊含著巨大的機會。數位平台和行動應用程式的推出,讓消費者更容易取得和使用這些卡片。隨著智慧型手機的普及和行動應用程式的便利性,藥品折扣卡可以被更廣泛的受眾接受,並為消費者帶來更多價值。

本研究的主要特點

  • 本報告對全球藥品折扣卡市場進行了詳細分析,包括預測期 2025-2032 的市場規模和複合年成長率(假設 2024 年為基準年)。
  • 它探索了各個領域的潛在收益成長機會,並為該市場提出了引人注目的投資提案矩陣。
  • 市場洞察:包括對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢和促進因素、區域展望以及主要企業採用的競爭策略的關鍵考慮因素。
  • 公司簡介:根據公司亮點、產品組合、財務表現和策略等參數,對藥品折扣卡市場的主要企業(如 GoodRx、SingleCare、WellCard Savings、RxSaver、Optum Perks、Kroger Prescription Savings Club、ScriptSave、Walmart Rx Savings Program、Prescription Hope、 產品系列 N Human.Need)進行介紹。
  • 這項研究將幫助負責人和經營團隊就產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 本報告涉及行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 已經使用了各種策略矩陣來分析全球藥品折扣卡市場,以方便相關人員做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
  • 處方藥價格高
  • 大量人口未投保者或保險不足
  • 線上平台的採用率提高
  • 州政府參與提供藥品折扣
    • 限制因素
  • 關鍵人群缺乏意識
  • 藥品和政府折扣計劃
    • 機會
  • 拓展新興市場
  • 非處方藥折扣卡
  • 為雇主提供客製化服務
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章 藥品折扣卡市場:COVID-19 疫情的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年藥品折扣卡市場類型

  • 品牌卡
  • 非專利卡

6. 2020 年至 2032 年按治療類別分類的藥品折扣卡市場

  • 心血管藥物
  • 糖尿病藥物
  • 止痛藥
  • 精神科藥物
  • 抗癌藥物
  • 其他

7. 2020 年至 2032 年藥品折扣卡市場(依銷售管道)

  • 線上
  • 離線
  • 老年人
  • 其他

8. 2020 年至 2032 年各地區藥品折扣卡市場

  • 北美洲
      • 美國
      • 加拿大
  • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韓國
      • 其他亞太地區
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中東和非洲
      • 海灣合作理事會國家
      • 以色列
      • 北非
      • 中部非洲
      • 其他中東和非洲地區

第9章 競爭態勢

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize
  • NeedyMeds
  • Humana

第 10 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6283

Drug Discount Card Market is estimated to be valued at USD 1,956.2 Mn in 2025 and is expected to reach USD 3,374.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1,956.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.10% 2032 Value Projection: USD 3,374.4 Mn

Drug discount cards have become a popular way for consumers to save money on prescription medications. With rising healthcare costs, these discount cards offer a much-needed financial relief to individuals and families. The concept is simple - individuals can present their drug discount card at participating pharmacies to receive discounted prices on their prescriptions.

Market Dynamics:

The drug discount card market is driven by several factors. Firstly, the increasing need for affordable healthcare options has led to a rise in the adoption of drug discount cards. With rising healthcare costs and high prescription drug prices, consumers are actively searching for ways to save money on their medications.

Another driver of this market is the growing prevalence of chronic diseases. As the number of individuals with chronic illnesses continues to rise, so does the demand for prescription medications. Drug discount cards provide an accessible and affordable solution for individuals who rely on medication to manage their conditions.

However, there are also certain restraints in the market. One of the challenges faced by drug discount cards is the lack of acceptance at all pharmacies. While many major pharmacies accept these cards, there are still some smaller pharmacies that do not participate in such programs. This limited acceptance can be a barrier for consumers who prefer to use local or independent pharmacies.

Despite these challenges, there are significant opportunities in the drug discount card market. The implementation of digital platforms and mobile applications has made it easier for consumers to access and use these cards. With the increasing adoption of smartphones and the convenience of mobile apps, drug discount cards can reach a wider audience and provide even more value to consumers.

Key features of the study:

  • The report provides an in-depth analysis of the global drug discount card market including market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • The study explores potential revenue growth opportunities across different segments and presents attractive investment proposition matrices for this market
  • Market Insights: The report presents key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • Company Profiles: Key players in the drug discount card market, such as GoodRx, SingleCare, WellCard Savings, RxSaver, Optum Perks, Kroger Prescription Savings Club, ScriptSave, Walmart Rx Savings Program, Prescription Hope, and FamilyWize, NeedyMeds and Humana are profiled based on parameters like company highlights, product portfolio, financial performance, and strategies
  • The study assists marketers and management authorities in making informed decisions regarding product launches, product upgrades, market expansion, and marketing tactics
  • The report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Various strategy matrices have been used in analyzing the global drug discount card market to provide stakeholders with ease in decision-making

Drug Discount Card Market Segmentation:

  • Drug Discount Card Market, By Type
    • Branded Cards
    • Generic Cards
  • Drug Discount Card Market, By Therapeutic Category:
    • Cardiovascular drugs
    • Diabetes drugs
    • Pain medications
    • Mental health medications
    • Cancer drugs
    • Others
  • Drug Discount Card Market, By Sales Channel
    • Online
    • Offline
  • Drug Discount Card Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • GoodRx
    • SingleCare
    • WellCard Savings
    • RxSaver
    • Optum Perks
    • Kroger Prescription Savings Club
    • ScriptSave
    • Walmart Rx Savings Program
    • Prescription Hope
    • FamilyWize
    • NeedyMeds
    • Humana

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Drug Discount Card, By Type
    • Market Drug Discount Card, By Therapeutic Category
    • Market Drug Discount Card, By Sales Channel
    • Market Drug Discount Card, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • High Cost of Prescription Drugs
  • Large Uninsured and Underinsured Population
  • Increasing Online Adoption of Online Platform
  • Involvement of State Governments to Provide Drug Discounts
    • Restraints
  • Lack of Awareness among Key Demographics
  • Discount Programs by Pharmaceutical Companies as well as Government Organizations
    • Opportunities
  • Expansion into Emerging Markets
  • Discount Cards for OTC Drugs
  • Customized Services for Employers
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Drug Discount Card Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Drug Discount Card Market, By Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Branded Cards
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Generic Cards
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Drug Discount Card Market, By Therapeutic Category, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cardiovascular drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Diabetes drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Pain medications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Mental health medications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Cancer drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Drug Discount Card Market, By Sales Channel, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Offline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Senior Citizens
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Drug Discount Card Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Mn)
      • GCC
      • Israel
      • North Africa
      • Central Africa
      • Rest of Middle East & Africa

9. Competitive Landscape

  • GoodRx
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SingleCare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • WellCard Savings
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • RxSaver
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Optum Perks
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kroger Prescription Savings Club
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • ScriptSave
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Walmart Rx Savings Program
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Prescription Hope
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • FamilyWize
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NeedyMeds
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Humana
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us